1. Home
  2. MRBK vs IVA Comparison

MRBK vs IVA Comparison

Compare MRBK & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRBK
  • IVA
  • Stock Information
  • Founded
  • MRBK 2004
  • IVA 2011
  • Country
  • MRBK United States
  • IVA France
  • Employees
  • MRBK N/A
  • IVA N/A
  • Industry
  • MRBK Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRBK Finance
  • IVA Health Care
  • Exchange
  • MRBK Nasdaq
  • IVA Nasdaq
  • Market Cap
  • MRBK 123.4M
  • IVA 117.3M
  • IPO Year
  • MRBK 2017
  • IVA 2020
  • Fundamental
  • Price
  • MRBK $13.05
  • IVA $1.87
  • Analyst Decision
  • MRBK Hold
  • IVA Strong Buy
  • Analyst Count
  • MRBK 1
  • IVA 3
  • Target Price
  • MRBK $13.00
  • IVA $18.00
  • AVG Volume (30 Days)
  • MRBK 15.2K
  • IVA 10.9K
  • Earning Date
  • MRBK 10-25-2024
  • IVA 09-25-2024
  • Dividend Yield
  • MRBK 3.83%
  • IVA N/A
  • EPS Growth
  • MRBK N/A
  • IVA N/A
  • EPS
  • MRBK 0.95
  • IVA N/A
  • Revenue
  • MRBK $90,796,000.00
  • IVA $20,652,523.00
  • Revenue This Year
  • MRBK N/A
  • IVA N/A
  • Revenue Next Year
  • MRBK $11.67
  • IVA $469.85
  • P/E Ratio
  • MRBK $13.79
  • IVA N/A
  • Revenue Growth
  • MRBK N/A
  • IVA N/A
  • 52 Week Low
  • MRBK $8.26
  • IVA $1.53
  • 52 Week High
  • MRBK $14.24
  • IVA $4.75
  • Technical
  • Relative Strength Index (RSI)
  • MRBK 78.26
  • IVA 37.87
  • Support Level
  • MRBK $12.60
  • IVA $1.77
  • Resistance Level
  • MRBK $12.83
  • IVA $1.92
  • Average True Range (ATR)
  • MRBK 0.26
  • IVA 0.12
  • MACD
  • MRBK 0.04
  • IVA -0.02
  • Stochastic Oscillator
  • MRBK 100.00
  • IVA 48.93

About MRBK Meridian Corporation

Meridian Corp is a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three business segments including Bank, Wealth, and Mortgage. It generates maximum revenue from the Bank segment that consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income, and other sources.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: